20 March 2012

Akers Biosciences, Inc. ("ABI" or the "Company") Appointment of Joint Broker

Akers Biosciences Inc. (AIM: ABI) is pleased to announce that Rivington Street Corporate Finance has been appointed as Joint Broker to the Company, with immediate effect.
Thomas A. Nicolette President and CEO, Akers Biosciences, Inc Tel. +1 856 848 8698
Daniel Stewart & Company plc (Nominated Adviser and Broker) Noelle Greenaway, Corporate Finance
Martin Lampshire, Corporate Broking
Tel. +44(0)20 7776 6550
Jon Levinson
Rivington Street Corporate Finance
Tel. +44(0)20 7562 3357
About Akers Biosciences
Akers Biosciences, Inc. develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state